Variable | PHSC (n = 23) | PHS (n = 16) | P value |
---|---|---|---|
Age (y)a | 54.0 ± 9.9 | 54.4 ± 13.4 | 0.276 |
Male: female ratio | 20:3 | 11:5 | 0.235 |
Liver hepatitis cirrhosis | 14 (73.7) | 10 (62.5) | 0.716 |
Clinical manifestations | 11 (52.4) | 11 (73.3) | 0.500 |
Tumor markers | |||
AFP | 9 (47.4) | 5 (33.0) | 0.495 |
Ca19–9 | 5 (35.7) | 2 (14.3) | 0.385 |
CEA | 1 (6.7) | 0 | 0.999 |
Vascular invasion | 13 (56.5) | 4 (25.0) | 0.099 |
Intrahepatic metastasis | 9 (40.9) | 4 (25.0) | 0.490 |
Extrahepatic metastasis | 12 (57.1) | 6 (37.5) | 0.325 |